OpenVSafe by OpenVAERS
Search V-safe

BGF-31792-15314

3 vaccinations 8 coded responses 30 check-ins 8 free-text entries 0 call cases
Sex
Male
Age at first dose
46-50
ZIP prefix
328 / FL
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-14
    Survey response — day 0, dose 1
    MedDRA: Myalgia — Feeling: Good · Site: Pain
    Free text: Minor soreness in muscle receiving injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: Mild muscle pain at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain, Myalgia — Feeling: Good · Site: Pain
    Free text: Minor muscle pain at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: Mild pain in muscle at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-21
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-28
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-04
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-04
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue, Injection site pain — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Significant fatigue, other than that mild pain at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue, Injection site erythema, Injection site pain — Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Moderate fatigue coupled w minor pain at injection site and moderate redness at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  17. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-05
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-01-12
    Dose 3 — Pfizer-BioNTech
  27. 2022-02-04
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-02-04
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities
    Free text: I caught a Covid 19 infection in November 2021.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-02-09
    Survey response — day 28, dose 3
    MedDRA: Nasopharyngitis, Pre-existing disease, Respiratory tract congestion, Sneezing — Feeling: Fair
    Free text: Sneezing and congestion, but just either head cold or allergies. only head no other difficulties.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-02-16
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-02-23
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-04-13
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-07-17
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2023-01-12
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Pfizer-BioNTech
22021-02-04Pfizer-BioNTech
32022-01-12Pfizer-BioNTech No

Free text

Release 2 — day 0, dose 1

2021-01-14

Systemic reaction (other): Minor soreness in muscle receiving injection

Release 2 — days 1–6 daily, dose 1

2021-01-15

Systemic reaction (other): Mild muscle pain at injection site

2021-01-16

Systemic reaction (other): Minor muscle pain at injection site

2021-01-17

Systemic reaction (other): Mild pain in muscle at injection site

Release 3 — days 1–6 daily, dose 2

2021-02-06

Systemic reaction (other): Significant fatigue, other than that mild pain at injection site

2021-02-07

Systemic reaction (other): Moderate fatigue coupled w minor pain at injection site and moderate redness at injection site

Release 11 — 12 months, dose 2

2022-02-04

Symptoms: I caught a Covid 19 infection in November 2021.

Release 11 — day 28, dose 3

2022-02-09

Symptoms: Sneezing and congestion, but just either head cold or allergies. only head no other difficulties.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SDRespiratory tract congestion · · ✓
SDSneezing · · ✓
SROFatigue ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROMyalgia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release